LON:OPTI

OptiBiotix Health - OPTI Share Forecast, Price & News

GBX 11.25

0.00 (0.00%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: 11.03
▼
11.32
50-Day Range: 11
▼
14.69
52-Week Range: 10.60
▼
41.15

Volume: 44,468 shs
Average Volume: 82,545 shs
Market Capitalization: £10.26 million

P/E Ratio: 187.50
Dividend Yield: N/A
Price Target: N/A

About OptiBiotix Health (LON:OPTI) Stock

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.

Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OPTI Stock News Headlines

February 23, 2023 | lse.co.uk

OptiBiotix appoints CEO Stephen O'Hara as CEO of subsidiary

February 18, 2023 | marketwatch.com

Home Meal Replacement (HMR) Market 2023 : Global Industry Share, Key Dynamics and Forecast to 2028

March 22, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

January 15, 2023 | marketwatch.com

Home Meal Replacement (HMR) Market 2023 : Industry Analysis, Opportunities, Technology, Top Players and Growth Forecast 2028

December 5, 2022 | marketwatch.com

OptiBiotix Health Shares Fall on Discounted Fund Raising

October 24, 2022 | lse.co.uk

OptiBiotix Health gets approval to sell products in Saudi Arabia

August 30, 2022 | nz.finance.yahoo.com

Prebiotic Ingredients Market Size to Reach Around USD 20.78 Bn by 2030

August 24, 2022 | lse.co.uk

OptiBiotix shares plunge on "very difficult trading" in half-year

March 22, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

August 24, 2022 | marketwatch.com

OptiBiotix Health Sees 1H Sales Below Expectations; Shares Dive

August 23, 2022 | fool.co.uk

OptiBiotix Health

July 18, 2022 | benzinga.com

OptiBiotix Health (OTC:OPBXF), Earnings Estimates, EPS, and Revenue

July 18, 2022 | benzinga.com

OptiBiotix Health (OTC:OPBXF), Analyst Ratings, Price Targets, Predictions

July 11, 2022 | marketwatch.com

OptiBiotix Signs Selling, Manufacturing Joint Development Deal With Firmenich

June 28, 2022 | marketwatch.com

OptiBiotix 2021 Pretax Profit Rose on Higher Revenue; Says Making Good Progress in 2022

June 20, 2022 | lse.co.uk

OptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-off

May 31, 2022 | lse.co.uk

Launch of cholesterol reducing yoghurt

April 21, 2022 | msn.com

PM Boris Johnson announces new deals worth £1bn on India visit

March 31, 2022 | proactiveinvestors.com

OptiBiotix Health CEO Stephen O’Hara explains why it makes sense to spin off ProBiotix Health

March 31, 2022 | proactiveinvestors.com.au

OptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchange

February 28, 2022 | lse.co.uk

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

February 28, 2022 | marketwatch.com

OptiBiotix 2021 Sales, Gross Profit Rose as It Expanded to New Regions

February 9, 2022 | marketwatch.com

OptiBiotix Plans Territory, Product Line Expansions in 2022

January 30, 2022 | proactiveinvestors.com.au

Five at Five: Another FTSE 100 fall, rate rise coming, Optibiotix readies new generation of products, Biden turns on crypto and Tesla tanks

January 18, 2022 | proactiveinvestors.com

OptiBiotix Health says latest study supports case for LPLDL as an alternative to statins

January 11, 2022 | msn.com

SMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum with next gen microbiome-focused developments

January 11, 2022 | msn.com

SMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OPTI Company Calendar

Last Earnings: 9/24/2020
Today: 3/21/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:OPTI
Previous Symbol: LON:CMI
CUSIP: N/A
CIK: N/A
Web: www.optibiotix.com
Phone: +44-20-79338780
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX 0.06
Trailing P/E Ratio: 188.17
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £5.91 million
Net Margins: 470.44%
Pretax Margin: N/A
Return on Equity: 24.67%
Return on Assets: -4.48%

Debt

Debt-to-Equity Ratio: 4.51
Current Ratio: 8.39
Quick Ratio: 7.89

Sales & Book Value

Annual Sales: £1.26 million
Price / Sales: 8.14
Cash Flow: GBX 1.30 per share
Price / Cash Flow: 8.68
Book Value: GBX 25 per share
Price / Book: 0.45

Miscellaneous

Outstanding Shares: 91,190,000
Free Float: N/A
Market Cap: £10.26 million
Optionable: Not Optionable
Beta: 1.61

Key Executives

Mr. Stephen Patrick O'Hara
Founder, CEO & Exec. Director

Dr. Sofia Kolyda (Age 50)
Exec. Director of R&D and Exec. Director
Comp: $119.82k

Mr. Rene Kamminga
CEO of Functional Fibres & Director

Mr. Mark Kingsley Collingbourne (Age 57)
CFO & Sec.

Paul Cannings
Head of Operations & Quality

Kevin James Newman
Corp. Devel. Director

Mr. Karl Burkitt
Marketing Director

Key Competitors

View All Competitors

Insiders

René Kamminga
Bought 2,656 shares on 3/24/2022
Total: £100,928.00 ($38.00/share)

View All Insider Transactions

OPTI Stock - Frequently Asked Questions

How have OPTI shares performed in 2023?: OptiBiotix Health's stock was trading at GBX 13.25 on January 1st, 2023. Since then, OPTI stock has decreased by 15.1% and is now trading at GBX 11.25.
View the best growth stocks for 2023 here.
How were OptiBiotix Health's earnings last quarter?: OptiBiotix Health Plc (LON:OPTI) posted its earnings results on Thursday, September, 24th. The company reported ($0.70) EPS for the quarter. OptiBiotix Health had a net margin of 470.44% and a trailing twelve-month return on equity of 24.67%.
What other stocks do shareholders of OptiBiotix Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include Digital Globe Services (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO).
What is OptiBiotix Health's stock symbol?: OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI."

How do I buy shares of OptiBiotix Health?: Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is OptiBiotix Health's stock price today?: One share of OPTI stock can currently be purchased for approximately GBX 11.25.
How much money does OptiBiotix Health make?: OptiBiotix Health (LON:OPTI) has a market capitalization of £10.26 million and generates £1.26 million in revenue each year. The company earns £5.91 million in net income (profit) each year or GBX 0.06 on an earnings per share basis.
How can I contact OptiBiotix Health?: OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The official website for the company is www.optibiotix.com. The company can be reached via phone at +44-20-79338780.

This page (LON:OPTI) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial